Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing
about
USING SOMATIC MUTATION DATA TO TEST TUMORS FOR CLONAL RELATEDNESS.Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating studyIdentifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.Liquid biopsies come of age: towards implementation of circulating tumour DNA.Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.Desmoplastic melanoma with sarcomatoid dedifferentiation.Challenges and opportunities for next-generation sequencing in companion diagnostics.A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system.Contralateral breast cancers: Independent cancers or metastases?Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer.Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer.
P2860
Q31027206-5B4E189D-EE9F-470B-8D88-9118EB243E03Q33579776-38321675-930E-4700-9781-81E791F57C31Q35836960-A4A5A1A4-8910-459A-AA8D-EA1BD0EB22DAQ37046429-3EE39BA2-89D3-4E35-B8C8-7182ACA86A07Q37232177-A11A0DD4-5503-461D-A3AD-FE988EFCBB68Q37706289-BF20B4AC-5412-4099-ACDC-515D4907E58DQ38390966-4C8DE627-DF38-4FB9-902E-348882A5433AQ38717805-6F27E21C-1EDB-441D-8CAD-024016B813FAQ39149201-85882AE9-5DE2-4E57-A1CC-6D779A7034E3Q41571576-53D2113A-5E99-46CE-81BA-D50588972953Q43232607-6134E505-BF09-44E9-8BDD-A1C526B97645Q43891611-035A53D9-490A-490C-8A34-8C5AF6402BBFQ45067635-980ED844-7B66-46BF-8087-DDC37A649AAFQ47683672-3096521B-BED8-4DB5-AE5C-07D8CFE4AF8AQ48005561-2141D3F6-A644-49FC-A1D8-D3F1F038FFC1Q48655131-32F4E46D-3BC0-4BB6-AB0D-2C6B13B2A1A3Q52904961-D9D15B85-C96F-480A-823F-7F195901E298Q55505567-BD60C490-675F-46A5-9A7A-31348943AEA5
P2860
Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Establishing the origin of met ...... massively parallel sequencing
@en
type
label
Establishing the origin of met ...... massively parallel sequencing
@en
prefLabel
Establishing the origin of met ...... massively parallel sequencing
@en
P2093
P2860
P50
P1433
P1476
Establishing the origin of met ...... massively parallel sequencing
@en
P2093
Helen H Won
Leticia De Mattos-Arruda
Michael F Berger
P2860
P304
P356
10.1016/J.MOLONC.2013.10.006
P50
P577
2013-10-31T00:00:00Z